Use clinical features of thyrotoxic periodic paralysis, happens after treating the thyroid disease in thyrotoxic periodic paralysis, and happens to serum potassium and CMAP during hypokalemic periodic paralysis. to frame the working diagnosis and next step; treat it as a safety constraint before prescribing or reassuring. Make happens after treating the thyroid disease in thyrotoxic periodic paralysis the checkpoint that determines whether you escalate testing, narrow the differential, or change treatment.

Thyrotoxic periodic paralysis combines hypokalemic weakness with thyrotoxicosis and arrhythmia risk; Thyroid treatment can resolve the paralysis and prevent recurrence; Low serum potassium and reduced CMAP amplitude support hypokalemic attacks; Andersen-Tawil syndrome carries substantial arrhythmic and sudden-death risk; Cardiac rhythm monitoring is central in periodic paralysis syndromes